Skip to content

A Study to Evaluate the Effect of Funk It Cycle Bites on PMS

An Open-Label, Single-Group Study to Evaluate the Effect of Funk It Cycle Bites on PMS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05900024
Enrollment
30
Registered
2023-06-12
Start date
2023-05-01
Completion date
2023-10-01
Last updated
2024-02-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premenstrual Syndrome

Brief summary

This is a virtual, open-label, single-group study that will last 4 menstrual cycles. All participants will complete a questionnaire at the end of their first period after enrolling (baseline/non-intervention cycle 1), then proceed to take the product daily and complete questionnaires at the end of their next 3 periods (intervention cycles 1, 2, and 3). The study will involve 30 female participants with regular menstrual cycles who experience PMS. Questionnaires will be used to monitor menstrual pain/cramps, energy levels, mood, and hormonal acne experienced before and during the menstrual cycle. Likert scale responses will be statistically compared from baseline to each check-in. Participant responses on product feedback will be presented as % scores.

Interventions

OTHERFunk It Cycle Bites

The intervention product contains: Organic Pumpkin Seed Butter, Prebiotic Agave Inulin, Organic Flax Seed, Organic Oat Flour, Organic Ginger, Quinoa Sprouts, Crispy Red Rice, Organic Cacao Nibs, Sunflower Seed Butter, Organic Reishi Mushroom, Organic Amaranth Seeds, Dates, Organic Button Mushroom, Acai Berry, Amla Fruit, Goji Berry, Pomegranate, Cranberry, Acerola (Cherry Juice), Rosemary Extract, Vitamin E (Mixed Tocopherols), Organic Vanilla Extract, Sea Salt, Cinnamon, Naturally Sourced Potassium Sorbate.

Sponsors

Citruslabs
CollaboratorINDUSTRY
Funk It Wellness
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Female aged 18-40 * Have a regular menstrual cycle (every 21-35 days). * Suffer from mild to moderate menstrual pain. * May experience mood swings and/or hormonal acne related to the menstrual cycle. * Otherwise generally healthy. * Willing to consume the test product with a ginger flavor. * Willing to refrain from taking any other supplements or prescription medications that may target the menstrual cycle or premenstrual syndrome (PMS) symptoms throughout the study period. * Willing and able to adhere to the study protocol, including taking supplements at the required times and completing questionnaires via the technology portal. * Able to communicate in English. * Participants must provide written informed consent (ICF).

Exclusion criteria

* Any unstable or uncontrolled medical or psychiatric illness. * Any uncontrolled chronic disease or condition that would prevent full participation in the study protocol. * A history of polycystic ovary syndrome (PCOS), endometriosis, premenstrual dysphoric disorder (PMDD), or undiagnosed vaginal bleeding. * Are taking hormonal contraception or exogenous sex hormones (estrogen, testosterone, progesterone), or have taken hormonal contraception or exogenous hormones in the past 6 months. * Are taking any prescription medication or supplements that target the menstrual cycle or PMS symptoms. * Are pregnant, breastfeeding, trying to become pregnant, or have been pregnant in the past 12 months. * Have any known severe allergic reactions, or any allergies of any severity to any of the test product's ingredients.

Design outcomes

Primary

MeasureTime frameDescription
Change in symptoms of premenstrual syndrome. [Time Frame: Baseline to Month 4]4 monthsSurvey-based assessment of symptoms using the Premenstrual Symptoms Screening Tool (PSST). Responses will be gathered using a 4-point Likert scale.
Changes in acne. [Time Frame: Baseline to Month 4]4 monthsSurvey-based assessment of acne using the Acne Quality of Life (Acne-QOL) scale. Responses will be gathered using a 5-point Likert scale.
Changes in pain levels, including menstrual cramps. [Time Frame: Baseline to Month 4]4 monthsSurvey-based assessment of acne using the Numerical Pain Rating Scale, a 0-10 point rating scale.
Changes in mood stability. [Time Frame: Baseline to Month 4]4 monthsSurvey-based assessment using study-specific questionnaires. Responses will be gathered using a 5-point Likert scale.
Changes in energy levels. [Time Frame: Baseline to Month 4]4 monthsSurvey-based assessment using study-specific questionnaires. Responses will be gathered using a 5-point Likert scale.

Secondary

MeasureTime frameDescription
Participant enjoyment of the product.4 monthsSurvey-based assessment using study-specific questionnaires. Responses will be gathered using a 5-point Likert scale.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026